<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/205038-epothilone-derivatives-and-their-synthesis by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 08:04:47 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 205038:EPOTHILONE DERIVATIVES AND THEIR SYNTHESIS</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">EPOTHILONE DERIVATIVES AND THEIR SYNTHESIS</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The invention relates to epothilone analog represented by formula (I) wherein (i) R2 is absent or oxygen; &quot;a&quot; can be either a single or double bond; &quot;b&quot; can be either absent or a single bond; and &quot;c&quot; can be either absent or a single bond, with the proviso that if R2 is oxygen then &quot;b&quot; and &quot;c&quot; are both a single bond and &quot;a&quot; is a single bond; if R2 is absent then **b&quot; and &quot;c&quot; are absent and &quot;a&quot; is a double bond; and if &quot;a&quot; is a double bond, then R2, &quot;b&quot; and &quot;c&quot; are absent; R3 is a radical selected from the group consisting of hydrogen; lower alkyl; -CH=CH2; -CCH; -CH2F; -CH2C1; -CH2-0H; -CH2-0-(Cl-C6-alkyl); and -CH2-S-(Cl-C6-alkyl); R4 and R5 are independently selected from hydrogen, methyl or a protecting group; and Rl is as defined in the specification, or a salt of a compound of formula (I) where a salt-forming group is present. A further aspect of the invention is related to the synthesis of epothilone E. These compounds have inter alia microtubule depolymerisation inhibiting activity and are e.g. useful against proliferative diseases.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td> <br><br><br>
The present invention relates to epothilone analogs having side chain modifications and to methods for producing such compounds, their use in the therapy of diseases or for the manufacture of pharmaceutical preparations for the treatment of diseases, as well as to novel intermediates used in the synthesis of such analogs and new methods of synthesis.<br>
Background of the invention<br>
The epothilones (1-5) are natural substances which exhibit cytotoxicity even against paclita-xel-resistant tumor cells by promoting the polymerization of a- and p-tubulin subunits and stabilizing the resulting microtubule assemblies. Emotions displace palliate (the active principle of TAXOL ") from its microtubule binding site and are reported to be more potent than palliate with respect to the stabilization of microtubules.<br><br>
What is needed are analogs of epothilone A and B that exhibit superior pharmacological properties, especially one or more of the following properties: an enhanced therapeutic index (e.g. a larger range of cytotoxic doses against e.g. proliferative diseases without toxicity to normal cells), better pharmacokinetic properties, better phannacodynamic properties, better solubility in water, better efficiency against tumor types that are or become resistant<br><br>
to treatment with one or more other chemotherapeutics, better properties to agitate manufacture of formulations, e.g. better solubility in polar solvents, especially those composing water, enhanced stability, convenient manufacture of the compounds as such, improved inhibition of proliferation at the cellular level, high levels of microtubule stabilizing effects, and/or specific phannacologic profiles.<br>
Detailed description of the invention:<br>
The present invention relates to new compounds that surprisingly have one or more of the<br>
above-mentioned advantages.<br>
One major aspect of the invention relates to an epottiilone analog compound represented by the formula I<br><br>
wherein<br>
the waved bond indicates that bond "a" is present either in the  or in the trans form;<br>
(1) R2 is absent or oxygen; "a" can be either a single or double bond; 'b" can be either absent or a single bond; and "c" can be either absent or a single bond, with the proviso that if Rj is oxygen then "b" and V are both a single bond and V is a single bond; if R2 is absent then V and "c" are absent and V is a double bond; and if "a" is a double bond, then Rj, V and "c" are absent;<br>
  a radical selected from the group consisting of hydrogen; lower alkyl, especially methyl, ethyl, n-propyl. iso-propyl, n-butyl. iso-butyl, tert-butyl. n-pentyl, n-hexyl; -CH=CH2;<br>
 ; -CH2F; -CH2CI; -CH2-OH; -CH2-0  especially -CHj-O-CHs; and -CHj-S-  especially -CH2-S-CH3;<br>
R4 and R5 are independently selected from hydrogen, methyl or a protecting group, preferably hydrogen; and<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br>
WE CLAIM:<br>
1.        An epothilone compound represented by the formula I<br><br>
Wherein<br>
The waved bond indicates that bond "a" is present either in the is or in the trans form;<br><br><br><br><br><br><br><br><br><br><br>
Wherein  has the meanings given under formula I in claim 1.<br><br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1hYnN0cmFjdC5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1hc3NpZ25tZW50LnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-assignment.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1jbGFpbXMgZmlsZWQucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-claims filed.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1jbGFpbXMgZ3JhbnRlZC5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-claims granted.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1jb3JyZXNwb25kZW5jZS1vdGhlcnMucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-correspondence-others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1jb3JyZXNwb25kZW5jZS1wby5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-correspondence-po.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1kZXNjcmlwaXRpb24oY29tcGxldGUpIGZpbGVkLnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-descripition(complete) filed.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1kZXNjcmlwaXRpb24oY29tcGxldGUpIGdyYW50ZWQucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-descripition(complete) granted.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1mb3JtIDEucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1mb3JtIDI2LnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-form 26.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1mb3JtIDMucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1mb3JtIDUucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1vdGhlciBkb2N1bWVudHMucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-other documents.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDAtODQxLWNoZS1wY3QucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2000-841-che-pct.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="205037-a-liquid-nutritional-composition-for-a-person-having-renal-failure.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="205039-an-enantiomer-pure-2-4-disubstituted-oxazolines-of-formula-1.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>205038</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>IN/PCT/2000/841/CHE</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>26/2007</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>29-Jun-2007</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>13-Mar-2007</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>18-Dec-2000</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>M/S. NOVARTIS AG</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>SCHWARZWALDALLEE 215, CH-4058 BASEL</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>FINLAY MAURICE RAYMOND VERSCHOYLE</td>
											<td>3550 NOBLE DRIVE, NO 6219 SAN DIEGO CA 92122</td>
										</tr>
										<tr>
											<td>2</td>
											<td>HE</td>
											<td>3950 MAHAILA AVENUE NO J-36,SAN DIEGO CA 92122</td>
										</tr>
										<tr>
											<td>3</td>
											<td>ROSCHANGAR</td>
											<td>FRANK 5101 COPPER RIDGE DRIVE NO 303 DURHAM NC 27707</td>
										</tr>
										<tr>
											<td>4</td>
											<td>VOURLOUMIS</td>
											<td>DIONISION 4249 NOBLE DRIVE NO 39 SAN DIEGIO , CA 92122</td>
										</tr>
										<tr>
											<td>5</td>
											<td>VALLBERG</td>
											<td>MANGARDSVAGEN 10, S-141 51 HUDDINGE SWEDEN</td>
										</tr>
										<tr>
											<td>6</td>
											<td>BIGOTANTONY</td>
											<td>3969 NOBEL DRIVE, NO, 273 SAN DIEGO CA CA 92122</td>
										</tr>
										<tr>
											<td>7</td>
											<td>NICOLAOU KYRIACOS</td>
											<td>9625 BLACKGOLD ROAD, LA JOLLA,CA 92037</td>
										</tr>
										<tr>
											<td>8</td>
											<td>KING NIGELPAUL</td>
											<td>3550 LEBON DRIVE, NO 6219 SAN DIEGO CA 92122</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C 07D 417/06</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP99/04287</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>1999-06-21</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>09/102,602</td>
									<td>1998-06-22</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/205038-epothilone-derivatives-and-their-synthesis by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 08:04:48 GMT -->
</html>
